Financials
- Market Capitalization 668.36 M
- Employee 102
- Founded 2010
- CEO Brian Stuglik
- Website www.verastem.com
- Headquarter Massachusetts, United States
- FIGI BBG001J2LSK5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.56
Relación precio/flujo de caja
17.31
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2712 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.85 USD | +0.94% | -0.84% | +21.91% | +11.37% | 703.70 M USD | ||
| 2725 | HELP Cybin Inc. - Common Stock | 13.24 USD | -2.86% | +5.25% | +74.67% | +47.60% | 683.61 M USD | ||
| 2743 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 10.75 USD | -1.01% | +5.19% | +47.46% | +42.20% | 668.21 M USD | ||
| 2747 | PRME Prime Medicine, Inc. - Common Stock | 3.64 USD | +1.68% | +10.98% | +18.57% | +5.20% | 660.21 M USD |